Published in Transplantation on December 01, 1972
Multiple common properties of human beta2-microglobulin and the common portion fragment derived from HL-A antigen molecules. Proc Natl Acad Sci U S A (1973) 2.08
Common antigenic structures of HL-A antigens. II. Small fragments derived from papain-solubilized HL-A antigen molecules. Immunology (1974) 1.05
Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. J Natl Cancer Inst (1972) 10.15
The Zone of Localization of Anti-Mouse-Kidney Serum as Determined by Radioautographs. Science (1949) 8.12
Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol (1992) 5.93
Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol (1988) 5.75
The 5'-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med (1990) 5.46
A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun (1997) 5.25
Nucleotide sequence of the genomic RNA of hepatitis C virus isolated from a human carrier: comparison with reported isolates for conserved and divergent regions. J Gen Virol (1991) 5.03
A SIMPLIFIED LYOPHIL APPARATUS. Science (1944) 4.56
Culture of normal human leukocytes. JAMA (1967) 4.50
e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med (1976) 4.01
Immunochemical structure of hepatitis B e antigen in the serum. J Immunol (1983) 3.50
Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med (1996) 3.13
Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93
Fluorescein as an Agent in the Differentiation of Normal and Malignant Tissues. Science (1947) 2.92
Use of Radioactive Diiodofluorescein in the Diagnosis and Localization of Brain Tumors. Science (1948) 2.74
Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from the 5'-noncoding region. Jpn J Exp Med (1990) 2.72
Defective immune-adherence (C3b) receptor on erythrocytes from patients with systemic lupus erythematosus. Lancet (1981) 2.64
Demonstration of hepatitis B e antigen in the core of Dane particles. J Immunol (1979) 2.56
A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology (1983) 2.49
Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47
The T-box transcription factor gene TBX22 is mutated in X-linked cleft palate and ankyloglossia. Nat Genet (2001) 2.46
Hepatitis B virus with mutations in the core promoter for an e antigen-negative phenotype in carriers with antibody to e antigen. J Virol (1994) 2.41
Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med (1994) 2.38
Cell lines from human colon carcinoma with unusual cell products, double minutes, and homogeneously staining regions. Cancer Res (1979) 2.31
Hepatitis B viruses with precore region defects prevail in persistently infected hosts along with seroconversion to the antibody against e antigen. J Virol (1990) 2.30
Surgical adjuvant chemotherapy in cancer of the breast: results of a decade of cooperative investigation. Ann Surg (1968) 2.29
Number of binding sites of rabbit macroglobulin antibody and its subunits. Immunochemistry (1965) 2.16
Multiple common properties of human beta2-microglobulin and the common portion fragment derived from HL-A antigen molecules. Proc Natl Acad Sci U S A (1973) 2.08
Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci U S A (2006) 2.08
Naturally occurring escape mutants of hepatitis B virus with various mutations in the S gene in carriers seropositive for antibody to hepatitis B surface antigen. J Virol (1994) 2.05
Evidence that celiac disease is primarily associated with a DC locus allelic specificity. Clin Immunol Immunopathol (1983) 2.02
Fivefold enlargement of implants in a splenic autotransplant recipient. Surgery (1993) 1.96
Culture of human leukemia cells. Cancer (1966) 1.94
Subsets of human Ia-like molecules defined by monoclonal antibodies. Mol Immunol (1981) 1.87
The pathogenesis of experimental membranous glomerulonephritis induced with homologous nephritogenic tubular antigen. J Exp Med (1976) 1.87
Tumor and lymphoid cell lines from a patient with carcinoma of the colon for a cytotoxicity model. Cancer Res (1978) 1.86
Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol (1998) 1.82
Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups. Proc Natl Acad Sci U S A (1994) 1.81
Antibodies against synthetic oligopeptides deduced from the putative core gene for the diagnosis of hepatitis virus infection. Hepatology (1992) 1.81
The genetic aetiology of Silver-Russell syndrome. J Med Genet (2007) 1.78
A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees. Proc Natl Acad Sci U S A (1986) 1.74
Hepatitis C virus variants from Jakarta, Indonesia classifiable into novel genotypes in the second (2e and 2f), tenth (10a) and eleventh (11a) genetic groups. J Gen Virol (1996) 1.72
Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods (1999) 1.70
The life span of the cultured normal cell: concepts derived from studies of human lymphoblasts. J Theor Biol (1968) 1.68
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy. Gut (2008) 1.68
Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis. Ann Intern Med (1995) 1.63
A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg. Gastroenterology (1979) 1.63
Imprinting of IGF2 P0 transcript and novel alternatively spliced INS-IGF2 isoforms show differences between mouse and human. Hum Mol Genet (2006) 1.63
Serological Reactions with Simple Substances Containing Two or More Haptenic Groups. Proc Natl Acad Sci U S A (1941) 1.60
Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: comparison with genomes of the other three subtypes. J Gen Virol (1986) 1.59
Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions. Virology (1999) 1.59
Hepatitis C virus variants from Nepal with novel genotypes and their classification into the third major group. J Gen Virol (1994) 1.59
Leukocyte cultures of patients with leukemia and lymphomas. N Y State J Med (1966) 1.55
IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity. Proc Soc Exp Biol Med (1965) 1.55
Elevated placental expression of the imprinted PHLDA2 gene is associated with low birth weight. J Mol Med (Berl) (2006) 1.53
The entire nucleotide sequences of three hepatitis C virus isolates in genetic groups 7-9 and comparison with those in the other eight genetic groups. J Gen Virol (1998) 1.52
Cytogenetic study of human lymphoid T-cell lines derived from lymphocytic leukemia. J Natl Cancer Inst (1974) 1.51
Moderate physical activity is associated with higher bone mineral density in postmenopausal women. J Am Geriatr Soc (2001) 1.50
A 49,000-dalton polypeptide bearing all antigenic determinants and full immunogenicity of 22-nm hepatitis B surface antigen particles. J Immunol (1980) 1.50
Soft tissue sarcomas. Ann Surg (1975) 1.49
Production and characterization of agglutinating monoclonal antibodies against predominant antigenic factors for Candida albicans. J Clin Microbiol (1986) 1.49
Phosphorylation in the carboxyl-terminal domain of the capsid protein of hepatitis B virus: evaluation with a monoclonal antibody. J Virol (1991) 1.48
Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48
Immunoglobulin production in human leukemia cell lines. J Immunol (1966) 1.47
Hepatitis C virus variants from Thailand classifiable into five novel genotypes in the sixth (6b), seventh (7c, 7d) and ninth (9b, 9c) major genetic groups. J Gen Virol (1995) 1.46
Demonstration of two distinct antigenic determinants on hepatitis B e antigen by monoclonal antibodies. J Immunol (1982) 1.44
Silver-Russell syndrome: a dissection of the genetic aetiology and candidate chromosomal regions. J Med Genet (2001) 1.43
Production of lymphotoxin and migration inhibitory factor by established human lymphocytic cell lines. J Immunol (1970) 1.43
Linkage of an X-chromosome cleft palate gene. Nature (1987) 1.42
The entire nucleotide sequence and classification of a hepatitis C virus isolate of a novel genotype from an Indonesian patient with chronic liver disease. J Gen Virol (1994) 1.41
Point mutation in the S gene of hepatitis B virus for a d/y or w/r subtypic change in two blood donors carrying a surface antigen of compound subtype adyr or adwr. J Virol (1987) 1.41
Response to interferon-alpha 2a in patients with e antigen-negative chronic hepatitis B. J Clin Gastroenterol (1997) 1.40
Immunoadsorbents with high capacity. Immunochemistry (1965) 1.39
Comparison of a rebound tonometer with an applanation tonometer in dogs with glaucoma. Vet Rec (2012) 1.39
The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities. Immunol Rev (1982) 1.39
Chronic active hepatitis with hepatitis B virus DNA and antibody against e antigen in the serum. Disturbed synthesis and secretion of e antigen from hepatocytes due to a point mutation in the precore region. Gastroenterology (1990) 1.38
Cytogenetic homogeneity in eight independent sites in a case of malignant melanoma. Cancer Genet Cytogenet (1993) 1.38
Maternal uniparental disomy 7 in Silver-Russell syndrome. J Med Genet (1997) 1.37
Response to interferon of GB virus C and hepatitis C virus in patients with chronic hepatitis. Am J Gastroenterol (1997) 1.37
Isolation of rabbit IgA antihapten antibody and demonstration of skin-sensitizing activity in homologous skin. J Exp Med (1966) 1.37
Anti-serum to cultured human lymphoblasts: preparation, purification and immunosuppressive properties in man. Ann Surg (1969) 1.37
Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immunoglobulin level with the generation cycle. J Immunol (1969) 1.36
Correlation between anti-HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang (1992) 1.35
Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation (1973) 1.35
Laboratory model of membranous glomerulonephritis in rats induced by pronase-digested homologous renal tubular epithelial antigen. Lab Invest (1975) 1.34
High terminal deoxynucleotidyl transferase activity in a new T-cell line (RPMI 8402) of acute lymphoblastic leukemia origin. J Natl Cancer Inst (1975) 1.33
The entire nucleotide sequence of a TT virus isolate from the United States (TUS01): comparison with reported isolates and phylogenetic analysis. Virology (1999) 1.30